Company D&D Pharmatech Inc.

Equities

A347850

KR7347850000

Biotechnology & Medical Research

Business Summary

Share class

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
31,500 ^KRW	0.00%		+22.57%	0.00%

May. 25	Certain Common Stock of D&D Pharmatech Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2024.	CI
May. 10	Certain Common Stock of D&D Pharmatech Inc. are subject to a Lock-Up Agreement Ending on 10-MAY-2024.	CI

DND Pharmatech Inc is a Korea-based clinical-stage biotech company mainly engaged in the research and development in medicines. The Company's product pipeline mainly focuses on indications including metabolic disease, neurodegenerative and fibrotic diseases. In addition, the Company is engaged in the research and development of therapeutic medicines used for diabetes, obesity and nonalcoholic steatohepatitis as well as others.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	10,515,689	10,515,689 ( 100.00 %)	0	100.00 %

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
D&D PHARMATECH INC.	0.00%	239M
VERTEX PHARMACEUTICALS INCORPORATED	+15.58%	121B
REGENERON PHARMACEUTICALS, INC.	+16.60%	110B
ARGENX SE	+18.75%	25.93B
BIONTECH SE	-24.33%	19.27B
GENMAB A/S	-19.33%	16.01B
BEIGENE, LTD.	-17.95%	15.66B
WUXI APPTEC CO., LTD.	-46.81%	14.89B
SAREPTA THERAPEUTICS, INC.	+58.78%	14.47B
NEUROCRINE BIOSCIENCES, INC.	+4.91%	13.91B

Bio Therapeutic Drugs